257 related articles for article (PubMed ID: 23634190)
1. Diagnosis and treatment of impulse control disorders in patients with movement disorders.
Mestre TA; Strafella AP; Thomsen T; Voon V; Miyasaki J
Ther Adv Neurol Disord; 2013 May; 6(3):175-88. PubMed ID: 23634190
[TBL] [Abstract][Full Text] [Related]
2. Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?
Toś M; Grażyńska A; Antoniuk S; Siuda J
Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391755
[TBL] [Abstract][Full Text] [Related]
3. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
Wolters ECh; van der Werf YD; van den Heuvel OA
J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
[TBL] [Abstract][Full Text] [Related]
5. Performance on the balloon analogue risk task and anticipatory response inhibition task is associated with severity of impulse control behaviours in people with Parkinson's disease.
Hall A; Weightman M; Jenkinson N; MacDonald HJ
Exp Brain Res; 2023 Apr; 241(4):1159-1172. PubMed ID: 36894682
[TBL] [Abstract][Full Text] [Related]
6. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
[TBL] [Abstract][Full Text] [Related]
8. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
[TBL] [Abstract][Full Text] [Related]
9. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.
Antonini A; Cilia R
Drug Saf; 2009; 32(6):475-88. PubMed ID: 19459715
[TBL] [Abstract][Full Text] [Related]
10. Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.
Maloney EM; Djamshidian A; O'Sullivan SS
J Neurol Sci; 2017 Mar; 374():47-52. PubMed ID: 28108021
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP).
Sharma A; Goyal V; Behari M; Srivastva A; Shukla G; Vibha D
Ann Indian Acad Neurol; 2015; 18(1):49-59. PubMed ID: 25745311
[TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum of impulse control disorders in Parkinson's disease.
Weintraub D; David AS; Evans AH; Grant JE; Stacy M
Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
[TBL] [Abstract][Full Text] [Related]
14. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
[TBL] [Abstract][Full Text] [Related]
15. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
16. The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Kon T; Ueno T; Haga R; Tomiyama M
Brain Behav; 2018 Aug; 8(8):e01036. PubMed ID: 29956879
[TBL] [Abstract][Full Text] [Related]
17. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
[TBL] [Abstract][Full Text] [Related]
18. Impulse control disorders in Parkinson's disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges.
Bhattacharjee S
Neurol India; 2018; 66(4):967-975. PubMed ID: 30038082
[TBL] [Abstract][Full Text] [Related]
19. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
[TBL] [Abstract][Full Text] [Related]
20. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
